As of 2025-12-26, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.01 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Pharmadrug Inc is -178.06%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 178.06%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.01 - -0.01 | -0.01 | -178.06% |
| DDM - Stable | (0.12) - 0.15 | 0.02 | 15.1% |
| DDM - Multi | (4.89) - 4.81 | (1,309.01) | -8726825.9% |
| Market Cap (mil) | 2.16 |
| Beta | -0.80 |
| Outstanding shares (mil) | 144.31 |
| Enterprise Value (mil) | 3.58 |
| Market risk premium | 5.10% |
| Cost of Equity | 3.51% |
| Cost of Debt | 5.00% |
| WACC | 3.96% |